Impact of TH and DCX mRNAs detection in high-risk neuroblastoma patients' outcome

被引：0
|
作者：
Canete, A. [1 ]
Yanez, Y. [1 ]
Grau, E. [1 ]
Palanca, S. [2 ]
Perez, G. [2 ]
Antuna, M. J. [3 ]
Marquez, C. [4 ]
Gallego, S. [5 ]
Urberuaga, A. [6 ]
Castel, V. [1 ]
机构：
[1] Hosp Univ & Politecn La Fe, Valencia, Spain
[2] Hosp Univ & Politecn La Fe, Mol Biol Lab, Valencia, Spain
[3] Hosp Univ Cent Asturias, Asturias, Spain
[4] Hosp Univ Virgen del Rocio, Seville, Spain
[5] Hosp Univ Vall dHebron, Barcelona, Spain
[6] Hosp Univ Cruces, Vizcaya, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1624
引用
收藏
页码：S356 / S357
页数：2
相关论文
共 50 条
  • [41] Genome-based outcome prediction in MYCN nonamplified high-risk neuroblastoma
    La Madrid, Andres Eduardo Morales
    Stricker, Thomas
    Pytel, Peter
    Gosiengfiao, Yasmin C.
    Shohet, Jason
    Shimada, Hiroyuki
    Furman, Wayne Lee
    Zage, Peter E.
    Park, Julie R.
    Perlman, Elizabeth
    Guerrero, Lisa
    Salwen, Helen
    Chlenski, Alexandre
    London, Wendy B.
    Cohn, Susan Lerner
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapy
    Yanishevski, David
    McCarville, M. Beth
    Doubrovin, Mikhail
    Spiegl, Hannah R.
    Zhao, Xiwen
    Lu, Zhaohua
    Federico, Sara M.
    Furman, Wayne L.
    Murphy, Andrew J.
    Davidoff, Andrew M.
    JOURNAL OF PEDIATRIC SURGERY, 2020, 55 (01) : 130 - 134
  • [43] Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
    Yanik, Gregory
    Naranjo, Arlene
    Parisi, Marguerite T.
    Shulkin, Barry L.
    Nadel, Helen
    Gelfand, Michael J.
    Ladenstein, Ruth
    Boubaker, Ariane
    Poetschger, Ulrike
    Valteau-Couanet, Dominique
    Kreissman, Susan G.
    Park, Julie R.
    Matthay, Katherine K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S107 - S107
  • [44] Dinutuximab: A Review in High-Risk Neuroblastoma
    Sheridan M. Hoy
    Targeted Oncology, 2016, 11 : 247 - 253
  • [45] Retinoid therapy of high-risk neuroblastoma
    Reynolds, CP
    Matthay, KK
    Villablanca, JG
    Maurer, BJ
    CANCER LETTERS, 2003, 197 (1-2) : 185 - 192
  • [46] Influence of Sarcopenia in High-risk Neuroblastoma
    Kawakubo, Naonori
    Souzaki, Ryota
    Koga, Yuuki
    Kinoshita, Yoshiaki
    Ohga, Shouichi
    Taguchi, Tomoaki
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S43 - S43
  • [47] The transcriptome landscape of high-risk neuroblastoma
    Wei, Jun S.
    Zhang, Shile
    Song, Young K.
    Asgharzadeh, Shahab
    Sindiri, Sivasish
    Wen, Xinyu
    Patidar, Rajesh
    Auvil, Jaime M. Guidry
    Gerhard, Daniela S.
    Seeger, Robert
    Maris, John M.
    Khan, Javed
    CANCER RESEARCH, 2016, 76
  • [48] High-Risk Neuroblastoma: A Surgical Perspective
    Jacobson, Jillian C.
    Clark, Rachael A.
    Chung, Dai H.
    CHILDREN-BASEL, 2023, 10 (02):
  • [49] Mouse models of high-risk neuroblastoma
    Alvin Kamili
    Caroline Atkinson
    Toby N. Trahair
    Jamie I. Fletcher
    Cancer and Metastasis Reviews, 2020, 39 : 261 - 274
  • [50] HIGH-RISK NEUROBLASTOMA: A Therapy in Evolution
    Fong, Abraham
    Park, Julie R.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2009, 26 (08) : 539 - 548
12345